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Objective: To determine whether dopamine prevents deterioration of central haemodynamics and renal function in 
aortoiliac surgery. 
Design: Prospective, randomised and placebo-controlled. 
Setting: University hospital. 
Materials: Thirty patients for elective vascular surgery with implantation of an aortobifemoral or an aortobiiliac graft due 
to aortoiliac arteriosclerosis had infusion of dopamine 3 i~g/kg/min orplacebo during the operation and 24 h postoperatively. 
Thoracic epidural analgesia nd general anaesthesia were used. 
Chief outcome measures: Central haemodynamic measurements were registered. The effective renal plasma flow (ERPF), 
the glomerular filtration rate (GFR), angiotensin II, aldosterone, arginine vasopressin (AVP), atrial natriuretic peptide 
(ANP), endothelin and excretion of water and electrolytes were measured preoperatively, 1 h postoperatively and 24 h 
postoperatively. 
Main results: During the operation the dopamine group had higher cardiac index and heart rate together with lower 
pulmonary artery wedge blood pressure. ERPF and GFR did not differ between the groups. In the dopamine group ERPF 
was increased in all patients at the first postoperative clearance. The fractional excretion of sodium, the per- and 
postoperative diuresis and AVP were increased in the dopamine group as compared to the placebo group. Postoperatively, 
ANP in the placebo group was raised as compared to the preoperative level. 
Conclusions: Peroperatively, dopamine counteracted depression of left ventricular function. The increased ERPF at the 
first postoperative cl arance in the dopamine group indicates either improved peroperative haemodynamics or a synergistic 
effect between dopamine and epidural sympathetic blockade. Dopamine also improved iuresis and natriuresis. 
Key Words: Anaesthesia-epidural; Aortic-abdominal surgery; Dopamine; Haemodynamics drug-effect; Renal circulation 
drug-effect; Randomised controlled trial. 
Introduction 
Decreased renal function may occur after infrarenal 
aortic surgery. 1'2 Effective renal plasma flow (ERPF) 
and glomerular filtration rate (GFR) decrease after 
aortic clamping and do not improve after declamp- 
ing. 3'4 The aetiology is unknown. 4 Optimal hydration, 
mannitol or dopamine may prevent deterioration of
56 the renal function.' The renal effects of low-dose 
dopamine have not been documented in these 
procedures. 6 
We conducted this prospective, randomised and 
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placebo-controlled study to examine the central hae- 
modynamics and renal function after aortoiliac sur- 
gery in arteriosclerotic patients, who had an infusion 
of placebo or dopamine 3 ~g/kg/min during the 
operation and postoperatively until the end of the last 
clearance measurement 24h postoperatively. 
Methods and Materials 
The study was approved by the Danish National 
Health Board and the Local Ethical Committee. The 
patients received oral and written information, gave 
their written consent, and were randomly allocated to 
infusion of dopamine or placebo. One of the authors 
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(L.dL.), unaware of the treatment allocation, anaes- 
thetised all the patients. 
Patients 
Thirty consecutive patients scheduled for elective 
vascular surgery with implantation of an aortobife- 
moral or an aortobiiliac graft due to aortoiliac occlu- 
sive arteriosclerosis were entered into the study. The 
function of both kidneys was proven to be normal by 
diethyl-triamine-pentaacetic acid (DTPA) 
renography. 
Exclusion criteria: Age more than 70 years; myocar- 
dial infarction within the last 3 years, the presence of 
cardiovascular symptoms or currently taking medica- 
tion; unstable angina and stable angina pectoris with 
congestive heart failure; cerebrovascular disease; dia- 
betes mellitus; hypertension (diastolic blood pressure 
_> 100 mmHg); medication with bronchodilator ther- 
apy or steroid. 
Exclusion of patients during the study: Treatment 
with inotropics or vasodilators because of heart 
failure; arrhythmias requiring antiarrhythmic therapy; 
loss of more than half of a patient's estimated blood 
volume; technical failure in sampling. 
Renal haemodynamics, hormones and electrolytes 
ERPF and GFR were measured the day before opera- 
tion and twice after (at haemodynamic stability 1 h 
postoperatively and 24 h postoperatively). On these 
three occasions the following hormones were ana- 
lysed: plasma level of angiotensin II, aldosterone, 
arginine vasopressin (AVP), atrial natriuretic peptide 
(ANP) and endothelin. On the same three occasions 
electrolytes and osmolality were analysed to allow 
calculation of the clearances of sodium, potassium, 
water and of osmolality. 
Anaesthesia and analgesia 
A combination of epidural analgesia and general 
anaesthesia was used. Premedication with diazepam 
10-15 mg p.o. was used 1 h before anaesthesia. A 
thoracic epidural catheter was inserted at Th 10-11 or 
one segment above or below. Bupivacaine plain 0.5%, 
10 ml, was injected. General anaesthesia was induced 
by midazolam 2.5-5 mg, fentanyl 3-5 /*g/kg and 
thiopentone as required (50-250 mg) to achieve 
unconsciousness. Pancuronium bromide 1 mg was 
injected as an anti-twitch agent before administration 
of succinylcholine 75-100 mg to facilitate tracheal 
intubation. A bolus dose of pancuronium bromide 6-8 
mg provided muscular elaxation. Epidural infusion 
of bupivacaine plain 0.5 %, 5 ml/hour, was maintained 
during the operation. A bolus dose of 3 ml was 
administered if commencement of laparotomy led to 
an increase in heart rate and blood pressure (heart rate 
> 100 beats/min, blood pressure above preoperative 
level). Halothane 0.4-1.0% (vaporiser concentration) 
in 50% oxygen/air was provided to maintain peroper- 
ative unconsciousness. Dopamine was administered 
from insertion of the Swan-Ganz catheter till the end 
of the last clearance measurement. 
Bolus doses of alfentanyl 0.5 mg were administered 
in case of signs of patient discomfort (elevated heart 
rate, dilated pupils or sweating). If myocardial ischae- 
mia was suspected according to the electrocardiogram 
(ECG) metoprolol 1 mg was injected as required. 
Ephedrine 2-5 mg was administered at hypotension 
while corrective measures were taken in terms of fluid 
infusion and adjustment of the level of anaesthesia. 
Norepinephrine bolus doses 2-5/xg replaced ephed- 
rine in cases of hypotension due to extreme vasodila- 
tion (systemic vascular esistance < 800 dyn/cm/s  s)
and if the response to ephedrine was excessive 
tachycardia. 
All patients had mid-line laparotomies with stan- 
dard exposure of the aorta that was cross-clamped just 
below the crossing of the left renal vein. The patients 
were scheduled to be extubated at the end of the 
operation and taken to the intensive care unit. Post- 
operatively epidural infusion continued with 5-8 ml/ 
h of bupivacaine plain 0.17% until midnight. From 
arrival in the intensive care unit epidural morphine 
3-4 mg was injected every 6-8 hs. Diuretics were not 
administered uring the study period. Droperidol 
boluses of 1.25 mg were used as an antiemetic. 
Monitoring 
The ECG (leads II and V5) and intravascular systemic 
arterial blood pressure were monitored continuously 
during induction of anaesthesia and during surgery. 
After induction of general anaesthesia  5-French 
thermodilution pulmonary artery catheter was 
inserted through the right internal jugular vein. The 
position was confirmed by inspection of the pressure 
wave. A nasopharyngeal temperature probe, a naso- 
gastric tube and a urinary bladder catheter were 
Eur J Vasc Endovasc Surg Vol 10, July 1995 
84 L, de Lasson et aL 
inserted. Peroperatively mean arterial blood pressure, 
mean pulmonary artery blood pressure, heart rate and 
central venous blood pressure were displayed con- 
tinuously. Pulmonary artery wedge blood pressure 
and cardiac output were measured as required. The 
haemodynamic observations were registered five 
times during the operation in all patients: (a) before 
skin incision, (b) before aortic cross clamping, (c) 5 
rain after clamping, (d) at completion of the vascular 
anastomoses, (e)at the end of the operation, and at the 
clearance measurements postoperatively. 
Systemic arterial blood samples were analysed to 
adjust ventilation to normocapnia and adequate oxy- 
genation during the operation. 
Fluid treatment 
Before skin incision, fluid was administered to com- 
pensate for vasodilation caused by the epidural and 
general anaesthesia: Dextran 70, 60 mg/ml  with 
isotonic sodium chloride, 300-500 ml /m 2 and an equal 
volume of isotonic saline. Peroperatively, isotonic 
saline was infused to compensate for evaporation and 
third space loss: 600 ml /m 2, 400 ml /m 2 and 200 ml/ 
m 2 in the 1st, 2nd and 3rd hour of the operation, 
respectively. In addition isotonic saline was given in a 
volume equivalent to the volume of urine produced in 
the previous hour during the operation. Blood loss 
was substituted by Dextran 70 until a maximum dose 
of 1.5 g/kg. Human albumin was then given. In case 
of a red blood cell fraction less than 0.28 SAG-M blood 
was transfused per- and postoperatively. 
Postoperativel~ crystalloid infusion was main- 
tained at 60 ml/m2/h till next morning at 0600 h and 
120 ml/m2/h thereafter. Human albumin was given if 
hypovolaemia occurred (low pulmonary artery wedge 
pressure and normal systemic vascular esistance). 
Analysis 
Glomerular filtration rate and ERPF were determined 
by the constant infusion clearance method. 7 The 
reference substances were ~25iothalamate and 
131I-hippuran. 
Angiotensin II was measured by radioimmunoassay 
by a modification of the method bescribed by Kappel- 
gaard et al. 8 Radioimmunoassay was performed after 
previous extraction from plasma by Sep-pak C-18 
cartridges. The antibody was obtained from the 
Department ofClinical Physiology, Glostrup Hospital 
Denmark. Minimum detection level was 2 pmol/1 
plasma. The coefficients of variation were 12% (inter- 
assay) and 8% (intraassay). 
Aldosterone was measured by a slight modification 
of a previously described method. 9 Using a rabbit 
anti-aldosterone antibody (International CIS, France) 
radioimmunoassay was performed on a residue from 
plasma prepared by extraction with dichloromethane 
and purification on silicagel columns. Minimum 
detection level was 42 pmol/1. The coefficients of 
variation were 13% (interassay) and 9% (intraassay). 
Atrial natriuretic peptide was determined by radio- 
immunoassay as previously described. 1° ANP was 
extracted from plasma by means of Sep-pak C-18 
cartridges. For radioimmunoassay, rabbit anti-ANP 
antibody was obtained from the Department of 
Clinical Chemistr~ Bispebjerg Hospital Copenhagen, 
Denmark. The minimum detection level was 0.5 
pmol/1 plasma. The coefficients of variation were 12% 
(interassay) and 10% (intraassay). 
Arginine vasopressin was measured radioimmuno- 
logically by a slight modification of a method pre- 
viously described. 11 Before the assay procedure, 
plasma proteins were precipitated with cold acetone 
and lipids extracted with petroleum ether. Radio- 
immunoassay was performed using a rabbit anti-AVP 
antibody (ICM Immuno Chemicals, Tumba, Sweden). 
The minimum detection level was 0.5 pmol/1. The 
coefficients of variation were 13% (interassay) and 9% 
(intraassay). 
Immunoreactive endothelin (ir-ET) was measured 
by radioimmunoassay as previously described. ~2 
Endothelin was extracted from plasma using Sep-pak 
C-18 cartridges. For radioimmunoassay n antibody 
produced in our own laboratory was used. The cross 
reactivity with ET-2 and ET-3 was 54% for both 
whereas there was no cross reactivity with human or 
porcine big endothelin. The minimum detection level 
was 0.05 pmoll. The coefficients of variation were 11% 
(interassay) and 8% (intraassay). 
The osmolar concentration f urine was determined 
with an Advanced Cryomatic Osmometer, model 3C2 
(Advanced Instruments Inc, Mass., U.S.A.). Sodium 
and potassium in plasma nd urine were measured by 
routine methods at the Department of Clinical Chem- 
istry, Skejby Hospital, Denmark. The clearance data 
were standardized to a body surface area of 1.73 m 2. 
Statistics 
The Mann-Whitney and the non-parametric two-way 
analysis of variance tests were applied (significance 
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level 0.05). In case of inter-column variation, the intra- 
group differences were examined by the Wilcoxon test 
(significance l vel 0.02). Unless otherwise specified the 
results are presented as median with interquartiles in
brackets. 
Results 
Thirteen and 17 patients were included in the dopa- 
mine and placebo groups, respectively. In the dopa- 
mine group one patient was excluded due to a 
technical problem. In the placebo group five patients 
were excluded: one patient developed right heart 
failure during induction of anaesthesia, and the 
operation was cancelled; the four others were 
excluded due to reoperation, stroke, atrial fibrillation 
and a technical problem, respectively. The large 
number of exclusions were due to the strict but 
Table 1. Demographic data. Values are median (range) 
Dopamine Placebo 
Female/male 9/3 7/5 
Age (years) 63 (50-69) 60 (49-68) 
Height (m) 1.63 (1.54-1.71) 1.67 (1.44-1.81) 
Weight (kg) 63 (48-73) 66 (47-98) 
ASA II/ASA III 9/3 9/3 
ASA: Peroperative risk assessment according to The American 
Society of Anesthesiologists. 
mandatory exclusion criteria. Table 1 describes the 24 
patients who completed the protocol. The age, weight 
and height of the two groups were similar. 
In the dopamine group one patient with atrial 
fibrillation had an uneventful recovery after treat- 
ment. In the placebo group there was one post- 
operative death due to major stroke and three other 
patients with complications urvived: one patient 
developed paraplegia due to spinal cord ischaemia, 
one had subendocardial infarction and one had atrial 
fibrillation. 
The operative trauma in terms of duration of 
operation, aortic clamping time and blood loss was the 
same in the two groups (Table 2). During the operation 
ephedrine was administered to 11 patients in the 
dopamine group and to 10 patients in the placebo 
group. Two patients in the dopamine group had 
norepinephrine and two others had metoprolol. 
Postoperatively six patients in the dopamine group 
and two patients in the placebo group had anti-emetic 
treatment with droperidol (X2= 3, d.f. = 1, NS). Two 
patients in each group had norepinephrine infusion 
(0.02-0.06 ~g/kg /min)  during the postoperative night 
Table 2. Duration of the operation, aortic cross-clamping time and 
blood loss. Values are median (interquartiles) 
Dopamine Placebo 
OP (rain) 166 (152-182) 166 (148-195) 
ACC (min) 33 (25-38) 24 (20-31) 
BL (ml) 875 (563-1750) 850 (700-1425) 
OP: duration of the operation; ACC: aortic ross damping time; BL: 
blood loss. 
to relieve hypotension (systemic vascular resistance 
range 620-957 dyn/cm / sS). The norepinephrine infu- 
sion was stopped at least 1.5 h before the last clearance 
measurement. 
Central haemodynamics 
During the operation the two groups differed with 
respect to heart rate (p=0.005), cardiac index 
(p = 0.017) and pulmonary artery wedge blood pres- 
Table 3. Peroperative mean arterial blood pressure, pulmonary 
artery mean blood pressure and central venous blood pressure. 
Values are median (interquartiles). There were no inter-group 
differences 
a b c d e 
MAP (mmHg) 
Dopamine 
Placebo 
MPA (mmHg) 
Dopamine 
Placebo 
CVP (mmHg) 
Dopamine 
Placebo 
77 83 83 77 75 
(65-81) (77-92) (79-93) (67-83) (70-100) 
76 77 84 74 77 
(68-78) (70-87) (77-94) (66~1) (72-85) 
19 20 19 20 21 
(17-21) (16-23) (15-21) (19-23) (17-22) 
19 23 23 23 22 
(17-23) (19-28) (20-26) (19-26) (18--25) 
8 11 12 10 9 
(6-9) (8-15) (8-14) (8-13) (8-13) 
8 15 16 10 11 
(6-10) (11-17) (12-17) (8-15) (9-14) 
MAP: mean arterial blood pressure; MPA: mean pulmonary artery 
blood pressure; CVP: central venous blood pressure at: a, before 
incision; b, before damping; c,5 rain after clamping; d,after 
completion fthe vascular nastomoses; e, end of operation. 
sure (p = 0.017) (Fig. 1). The peroperative mean arterial 
blood pressure, pulmonary artery mean blood pres- 
sure and central venous blood pressure of the two 
groups did not differ (Table 3). 
Stroke volume index and systemic vascular esis- 
tance index did not differ between the groups. We did 
not attempt to estimate intra-group differences since a 
major vascular operation without variation in haemo- 
dynamics is highly unlikely. 
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Renal haemodynamics 
The two groups  d id  not  differ w i th  respect  to ERPF, 
but  there was  an in t ra -group dif ference in the dopa-  
mine group  and t ime- t reatment  interact ion for ERPF 
(p -- 0.009) (Fig. 2). The GFR d id  not  exhibit  in ter -group 
or in t ra -group differences. There was  no difference in 
the f i l trat ion fract ion ( io tha lamate /h ippuranc lear -  
ance) w i th  respect  to the groups.  In the doparn ine  
group the f i l trat ion fract ion was  lower  at the first 
postoperat ive  c learance compared  to that before 
operat ion:  a l though the GFR was  ra ised in nine 
Heart rate 
....q 
100 
80 
60 
t t 
a b c d e 
Cardiac index 
t t 
a b e d e 
Pulmonary artery wedge blood pressure 
::f tt :i iI ,t 
a b e d e 
Fig. 1. Peroperative haemodynamics. The two groups were different 
with respect o heart rate, cardiac index and pulmonary artery 
wedge pressure during the operation. Median and interquartiles: a, 
before incision; b, before aortic clamping; c, 5 rain after clamping; d, 
after completion of the vascular anastomoses; e, end of operation. 
(0) dopamine; (©) placebo. 
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_ x ,  
0 1 2 0 1 2 
Fig. 2. Effective renal plasma flow and glomerular filtration rate. 
Values are means of 2--3 measurements a : 0, preoperative measure- 
ment; 1, first postoperative measurement (at haemodynamic stabil- 
ity 1 h postoperatively); 2, second postoperative measurement (24 h 
postoperatively). ERPF: there was no inter-group difference, but 
there was time-treatment i eraction and in the dopamine group 
there was intra-group difference. GFR: no inter-group or intra- 
group difference. 
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patients at the first postoperative clearance measure- 
ment, compared to that before operation, the ERPF in 
these patients was raised even further leading to a 
lower filtration fraction. There was no time-treatment 
interaction. 
Water and electrolyte clearance 
The urine output during the operation was 720 ml 
(interquartiles 486-1700 ml) in the dopamine group 
and 220 ml (interquartiles 136-520 ml) in the placebo 
group, respectively (p= 0.0008). The postoperative 
urine output was 1933 ml (interquartiles 1440-2381 
ml) in the dopamine group and 1163 ml (interquartiles 
809-1550 ml) in the placebo group (p = 0.009). 
The fractional excretion of sodium varied between 
the groups (p = 0.033), with intra-group differences but 
Table 4. Fractional excretion of sodium, fractional excretion of 
potassium, osmolar clearance and free water clearance. Values are 
median (interquartiles) FENa,: inter-group difference. FEK, Cos m 
and CH2 0 no inter-group difference 
0 1 2 
FENa 
Doparnine 
Placebo 
FE K 
Dopamine 
Placebo 
Cos m (ml/min) 
Dopamine 
Placebo 
CH2 o (ml/mi~) 
Dopamine 
Placebo 
0.014 0.043 0.006 
(0.011-0.015) (0.029-0.068)t (0.003-0.008)-[ 
0.008 0.024 0.006 
(0.006-0.015) (0.011-0.051)* (0.003-0.008) 
0.24 0.34 0.16 
(0.21-0.27) (0.31-0.42)t- (0.14-0.20) 
0.22 0.23 0.14 
(0.14-0.32) (0.19-0.33) (0.11-0.19) 
2.37 5.57 1.82 
(1.91-2.73) (3.06-6.98)-[ (1.59-2.13)t- 
2.34 3.27 1.67 
(1.80--2.97) (2.12-5.20) (1.21-2.46) 
4.34 -1.41 -0.84 
(2.87-5.82) (-1.97--0.78)t (-1.02--0.73)t- 
3.70 -1.45 -0.83 
(2.56-4.50) (-2.42--0.99)t (-1.81--0.55)f 
Intra-group differences: *p<0.02, f p<0.01. Data at 1st and 2nd 
postoperative clearances were compared to the preoperative 
clearance. 
FENa: fractional excretion of sodium; FEK: fractional excretion of 
potassium; Costa: osmolar dearance and CH20: free water dearance at: 
0, preoperative measurement; 1, 1st,postoperative m asurement (at
haemodynamic stability 1 h postoperatively), 2, 2nd postoperative 
measurement (24 h postoperatively). 
no time-treatment i teraction (Table 4). The fractional 
excretion of potassium, the osmolar clearance and the 
free water clearance did not differ with respect o the 
groups; the intra-group differences are indicated in 
Table 4. There was no time-treatment interaction. 
Endocrine results 
Arginine vasopressin differed between the groups 
(p = 0.0005). There were intra-group differences inboth 
groups and time-treatment interaction (p=0.0003) 
(Fig. 3). Atrial natriuretic peptide did not differ 
between the groups (p = 0.068) but there was an intra- 
group difference in the placebo group (Fig. 3) and 
time-treatment i teraction (p = 0.046). 
Atrial natriuretic peptide 
O 
25 
20 
15 
10 
5 
t tt 
0 1 2 
Arginine vasopressin 
16 
14 
O 
12 
o 
10 
0 1 2 
- 65 536 
16 384 
4096 
- 1024 
- 256 
O 
Fig. 3. Atrial natriuretic peptide and arginine vasopressine. Values 
are median and interquartiles at: 0, preoperative measurement; 1, 
first postoperative measurement (at haemodynamic stability 1 h 
postoperatively); 2, second postoperative measurement (24 h 
postoperatively). ANP: no inter-group difference, but time-treat- 
ment interaction and intra-group difference in the placebo group. 
AVP: inter-group difference and intra-group differences in both 
groups and time-treatment interaction. (@) dopamine; (©) 
placebo. 
Eur J Vasc Endovasc Surg Vol 10, July 1995 
88 L. de Lasson et al. 
Aldosterone, angiotensin II and endothelin did not 
differ between the groups. The intra-group differences 
are stated in Table 5. There was no time-treatment 
interaction. 
Table 5. Aldosterone, angiotensin II and endothelin. Median 
(interquartiles). There were no inter-group differences among 
aldosterone, angiotensin II or endothelin 
0 1 2 
ALDO (pmol/1) 
Dopamine 
Placebo 
ANG II (pmol/1) 
Dopamine 
Placebo 
ET (pmol/1) 
Dopamine 
Placebo 
118 209 147 
(105-137) (176-263)f (111-158) 
132 186 119 
(109-142) (125-220) (84-157) 
18.7 13.9 23.0 
(9.6-30.7) (8.6-16.3) (16.3-39.4) 
14.4 14.9 19.7 
(11.0-30.5) (7.9-28.3) (12.546.3) 
0.87 0.77 0.79 
(0.80-0.96) (0.61-0.94)* (0.73-0.99) 
0.88 0.88 0.83 
(0.82-1.05) (0.75-1.0) (0.71-0.88) 
Intra-group differences: *p<0.02,t p<0.01. Data at 1st and 2nd 
postoperative measurements were compared to the preoperative 
measurement. 
ALDO: aldosterone; ANG II: angiotensin II and ET: endothelin at: 
0, preoperative measurement; 1, first postoperative measurement (a
haemodynamic stability I h postoperatively); 2, second postoperative 
measurement (24 h postoperatively). 
Discussion 
The morbidity and mortality of the patients in this 
study were similar to reported f igures. 13'14 The num-  
ber  of patients does not warrant the conclusion that 
infusion of low-dose dopamine improves outcome, 
although the only serious complications occurred in 
the placebo group. The patients who received dopa- 
mine had a higher cardiac index and lower pulmonary 
artery wedge blood pressure. These observations have 
previously been associated with improved 
survival. ~5,16 
The haemodynamic differences between the groups 
were unexpected, since dopamine 3 b~g/kg/min is 
ascribed only a renal vasodilating effect. The higher 
heart rate in the dopamine group during the operation 
accounts for the higher cardiac index to some extent, 
but the higher cardiac index was observed at a lower 
left ventricular filling pressure and at a peripheral 
vascular esistance qual to that of the placebo group. 
Thoracic epidural anaesthesia (TEA) causes reduced 
peripheral resistance l ading to peripheral vasodilata- 
tion and reduced venous return. The reduction of 
afterload is favourable to the left ventricle. The 
observed haemodynamic effect of dopamine should 
be seen in the context of cardiovascular depression 
and left ventricular dysfunction induced by extensive 
TEA and general anesthesia (GA). ~7-19 This has also 
been confirmed in animal study, z° A previous report 
demonstrated ifferent haemodynamic effects of 
dopamine during GA as compared to the effect during 
combined GA and extensive TEA. zl The central 
venous blood pressure (CVP) of the two groups did 
not differ which may be due to a number of reasons: 
CVP is a guide to replacement of blood loss and 
ventilation, abdominal packing and retractors influ- 
ence the right heart filling pressure much more than 
the left. In the placebo group the systemic blood 
pressure was adequately maintained espite vidence 
of decreased left ventricular function. This emphasises 
the fact that the arterial systemic blood pressure is a 
poor indicator of the haemodynamic condition. 
Anaesthetics generally depress kidney function. 22 A 
renal vasoconstriction caused by infra-renal aortic 
clamping is documented in humans and is not 
relieved immediately following declamping. 3'4 High 
values of ERPF have been reported previously during 
epidural blockade and have been related to the 
combination of renal sympathetic blockade and unim- 
paired systemic haemodynamics. 4 In the dopamine 
group the ERPF had a characteristic biphasic course. 
An increased ERPF was observed at the first post- 
operative clearance. The higher cardiac index peroper- 
atively in the dopamine group may have contributed 
to this. Our data indicate a synergistic effect of 
epidural blockade and dopamine or a reactive hyper- 
perfusion state secondary to release of renal vasocon- 
striction. The renal vasodilating effect of dopamine is 
23 24 mediated by specific dopamine receptors. ' Twenty- 
four hours postoperatively the ERPF was at the 
preoperative level despite ongoing dopamine infu- 
sion. At this time the depressing effect of anaesthetics 
with respect o cardiovascular and renal haemody- 
namics had disappeared as had the epidural blockade. 
This biphasic response of the ERPF in the dopamine 
group was seen in some patients in the placebo group, 
but the group as such did not reproduce the structured 
pattern of the dopamine group. The GFR was not 
significantly influenced by dopamine, which pre- 
viously has been reported to increase the ERPF 
without raising the GFR. 25 
The per- and postoperative urine output differed 
significantly in the two groups, and there was also a 
difference with respect o the fractional excretion of 
sodium. The diuretic and natriuretic responses to 
dopamine are well known and are due to a direct 
tubular action of dopamine, zsThis has been observed 
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with  or w i thout  an improvement  in renal  haemody-  
namics.  25"26 Dopamine  has prev ious ly  been shown to 
increase both  the fract ional  excret ion of potass ium and 
the osmolar  clearance. 26'27 
The peroperat ive  central  haemodynamic  results 
ind icat ing  depressed  left ventr icu lar  funct ion in the 
p lacebo group  were cor roborated  by  the ANP obser-  
vat ions.  Increased ANP level  is observed  in pat ients  
w i th  h igh atr ial  pressures  and  cardiac disease, and  one 
of the roles of ANP is to protect  he body  against  f lu id 
over load.  28'29 The AVP results in the dopamine  group  
were unexpected.  AVP has been ascr ibed a major  role 
in the regu lat ion  of arter ia l  b lood  pressure  dur ing  
ep idura l  b lockade,  3° and  the observat ions  in the 
dopamine  group  might  be dependent  on the left heart  
f i l l ing pressures  ince left atr ial  receptors  prov ide  one 
of the major  non-osmot ic  pathways  for AVP release. 31 
Other  t r iggers of AVP-release are nausea and  
opio ids.  32 Our  cl inical impress ion  was  that the 
pat ients  in the dopamine  group  more  often had  
nausea postoperat ive ly  but  there was no dif ference 
between the groups  wi th  respect  to ant iemet ic  treat- 
ment  or op io id  admin is t rat ion.  
In conclusion,  in fus ion of low-dose  dopamine  is 
recommended to counteract  depress ion  of the left 
ventr icu lar  funct ion due to extensive TEA and  general  
anaesthesia.  The increased effective renal  p lasma f low 
observed  postoperat ive ly  in the dopamine  group  is 
p robab ly  due  to improved peroperat ive  haemody-  
namics  in combinat ion  wi th  a synergist ic  effect of 
dopamine  and  the sympathet ic  b lockade  induced by  
TEA. The increased diures is  and  natr iures is  in the 
dopamine  group is an appropr ia te  postoperat ive  
response to reduce water  and  sod ium retent ion.  
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